Recombinant Human PDCD6IP, N-GST

Introduction

Recombinant Human PDCD6IP (Programmed Cell Death 6 Interacting Protein) is a protein that plays a crucial role in regulating cell death and survival pathways. It is a highly conserved protein found in various organisms, including humans. In this article, we will discuss the structure, activity, and applications of Recombinant Human PDCD6IP.

Structure of Recombinant Human PDCD6IP

Recombinant Human PDCD6IP is a 34 kDa protein composed of 295 amino acids. It contains a Phox homology (PX) domain and two calcium-binding EF-hand motifs. The PX domain is responsible for binding to phospholipids, while the EF-hand motifs are involved in calcium-dependent protein-protein interactions. The protein also has a C-terminal coiled-coil domain, which is crucial for its dimerization and interaction with other proteins.

Activity of Recombinant Human PDCD6IP

Recombinant Human PDCD6IP is a multifunctional protein that is involved in various cellular processes, including apoptosis, autophagy, and intracellular signaling. It interacts with several proteins, including Bcl-2, Bax, and Fas, to regulate cell death and survival pathways. It also plays a role in intracellular calcium homeostasis by binding to and regulating the activity of the inositol 1,4,5-trisphosphate receptor (IP3R).

One of the key functions of Recombinant Human PDCD6IP is its role in the regulation of autophagy. Autophagy is a cellular process that involves the degradation and recycling of cellular components to maintain cellular homeostasis. Recombinant Human PDCD6IP interacts with the autophagy-related protein Beclin-1 and plays a crucial role in the initiation of autophagy. It also regulates the fusion of autophagosomes with lysosomes, which is essential for the degradation of autophagic cargo.

Applications of Recombinant Human PDCD6IP

Recombinant Human PDCD6IP has various applications in both research and therapeutic settings. Its role in regulating cell death and survival pathways makes it a potential target for cancer therapy. Studies have shown that overexpression of PDCD6IP can induce apoptosis in cancer cells, making it a potential therapeutic target for cancer treatment.

Recombinant Human PDCD6IP is also used in research to study the mechanisms of autophagy and its role in various diseases. Its interaction with Beclin-1 and regulation of autophagy makes it a crucial protein in understanding the process of autophagy and its dysregulation in diseases such as neurodegenerative disorders and cancer.

Furthermore, Recombinant Human PDCD6IP has been used in studies to understand its role in calcium signaling and its interaction with IP3R. Dysregulation of calcium signaling has been linked to various diseases, and Recombinant Human PDCD6IP provides a valuable tool for studying this process.

Conclusion

Recombinant Human PDCD6IP is a multifunctional protein that plays a crucial role in regulating cell death and survival pathways, autophagy, and intracellular signaling. Its structure, with a PX domain, two EF-hand motifs, and a coiled-coil domain, allows it to interact with various proteins and regulate different cellular processes. Its applications in cancer therapy and research make it a valuable protein for understanding and treating various diseases. Further studies on Recombinant Human PDCD6IP may provide insights into its role in other cellular processes and its potential as a therapeutic target.